Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience
- PMID: 31587352
- PMCID: PMC7781435
- DOI: 10.1111/ejh.13335
Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience
Keywords: direct oral anti-coagulant; myeloproliferative; splanchnic vein; thrombosis.
References
-
- Falanga A, Marchetti M. Thrombotic disease in the myeloproliferative neoplasms. Hematology Am Soc Hematol Educ Program. 2012;2012:571–581. - PubMed
-
- Ageno W, Riva N, Schulman S, et al. Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry. JAMA Intern Med. 2015;175(9):1474–1480. - PubMed
-
- Lavu S, Szuber N, Mudireddy M, et al. Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases. Am J Hematol. 2018;93(3):E61–E64. - PubMed
-
- Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the S, Standardization Committee of the International Society on T, Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692–694. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
